Most-cited articles · 2019

The 10 most-cited articles in Experimental Biology and Medicine, 2019

Ranked by OpenAlex citation count on 29 October 2026, out of 173 eligible articles Experimental Biology and Medicine published in 2019. Ranks are frozen; this page will not change. Number one, with 207 citations: Necrotizing enterocolitis: It’s not all in the gut.

Cohort
173 articles
Listed
Top 10 (5.8%)
Open access
10 of 10
Snapshot
2026-10-29

The most-cited articles published in Experimental Biology and Medicine in 2019 cluster around several themes, including gastrointestinal and neurodevelopmental disease, cytoskeletal and mechanotransduction biology, and inflammation-linked conditions. The top paper, by Meister, Doheny, and Travagli, reviews necrotizing enterocolitis and has 207 citations. Other highly cited works examine Angelica polysaccharide effects on memory impairment in an Alzheimer's disease rat model, with 153 citations, and the roles of TRPV4 and Piezo channels in stretch-evoked calcium responses in chondrocytes, with 152 citations.

For readers, the list offers a snapshot of the subjects that drew the most citation attention among the journal's 2019 output, spanning basic mechanisms, disease models, and reviews. It can serve as a starting point for exploring frequently referenced work from that year.

Introduction written from the titles and abstracts on this list. Every figure below is the source.

Ask about these papers

Grounded in this list only, with sources.

3 of 3 free questions left today, no account needed
  1. 1
    top 0.6%

    Necrotizing enterocolitis: It’s not all in the gut

    Alissa L. Meister, Kim Kopenhaver Doheny, Renato Alberto Travagli

    207 citationsOpen accessdoi:10.1177/1535370219891971OpenAlex

    Show abstract

    Necrotizing enterocolitis is the leading cause of death due to gastrointestinal disease in preterm neonates, affecting 5–12% of neonates born at a very-low birth weight. Necrotizing enterocolitis can present with a slow and insidious onset, with some neonates displaying early symptoms such as feeding intolerance. Treatment during the early stages includes bowel rest and careful use of antibiotics, but surgery is required if pneumoperitoneum and intestinal perforation occur. Mortality rates among neonates requiring surgery are estimated to be 20–30%, mandating the development of non-invasive and reliable biomarkers to predict necrotizing enterocolitis before the onset of clinical signs. Such biomarkers would allow at-risk neonates to receive maximal preventative therapies such as careful nutritional consideration, probiotics, and increased skin-to-skin care. Impact statement Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease; its high mortality rate mandates the development of non-invasive biomarkers to predict NEC before its onset. This review summarizes the…

  2. 2
    top 1.2%

    Angelica polysaccharide ameliorates memory impairment in Alzheimer’s disease rat through activating BDNF/TrkB/CREB pathway

    Qian Du, Xiaoyu Zhu, Jieru Si

    153 citationsOpen accessdoi:10.1177/1535370219894558OpenAlex

    Show abstract

    This study aimed to investigate the effect of Angelica sinensis polysaccharides (ASP) on Alzheimer’s disease (AD) and its underlying mechanisms. In our study, we build the AD model by injecting Aβ 25–35 . Morris water maze (MWM) was applied to investigate learning and memory. Moreover, neurotransmitters, free radical, and inflammatory factors were also measured. Pathological change and neuronal death in hippocampus CA1, CA3, and DG region were detected by HE staining and Nissl staining. The neuronal apoptosis was detected by TUNEL. The expressions of caspase-3, Bcl-2 and Bax were measured by immunohistochemistry and Western blot. The expressions of BDNF, TrkB, p-Akt, Akt, p-CREB, and CREB were measured by Western blot. Our results showed that ASP could ameliorate spatial learning and memory deficiency in AD rats. ASP decreased AchE level and increased the levels of Ach and chAT in AD rats. ASP could increase the activity of SOD and CAT, decrease MDA activity, and inhibit the expression levels of inflammatory factors and neurons apoptosis in AD rats. Pathological change of…

  3. 3
    top 1.8%

    Roles of TRPV4 and piezo channels in stretch-evoked Ca 2+ response in chondrocytes

    Genlai Du, Li Li, Xinwang Zhang, Jianbing Liu, Jianqing Hao and 4 more

    152 citationsOpen accessdoi:10.1177/1535370219892601OpenAlex

    Show abstract

    Chondrocyte mechanotransduction is not well understood, but recently, it has been proposed that mechanically activated ion channels such as transient receptor potential vanilloid 4 (TRPV4), Piezo1, and Piezo2 are of functional importance in chondrocyte mechanotransduction. The aim of this study was to distinguish the potential contributions of TRPV4, Piezo1, and Piezo2 in transducing different intensities of repetitive mechanical stimulus in chondrocytes. To study this, TRPV4-, Piezo1-, or Piezo2-specific siRNAs were transfected into cultured primary chondrocytes to knock down (KD) TRPV4, Piezo1, or Piezo2 expression, designated TRPV4-KD, Piezo1-KD, or Piezo2-KD cells. Then we used Flexcell® Tension System to apply cyclic tensile strains (CTS) of 3% to 18% at 0.5 Hz for 8 h to the knockdown and control siRNA-treated cells. Finally, using a Ca 2+ imaging system, stretch-evoked intracellular Ca 2+ ([Ca 2+ ] i ) influx in chondrocytes was examined to investigate the roles of TRPV4, Piezo1, and Piezo2 in Ca 2+ signaling in response to different intensities of repetitive mechanical…

  4. 4
    top 2.4%

    Engineering the microbiome for animal health and conservation

    Se Jin Song, Douglas C. Woodhams, Cameron Martino, Celeste Allaband, Andre Mu and 3 more

    128 citationsOpen accessdoi:10.1177/1535370219830075OpenAlex

    Show abstract

    Interest in animal microbiomes as therapeutics is rapidly expanding, as techniques to study the microbial world decrease in cost and increase in accessibility and case studies from human medicine receive widespread attention. In this review, we summarize the current state of techniques to modify the microbiome to improve animal health, focusing on applications in domestic pets, farm animals, and in wild settings for conservation. We discuss options for modifying the microbiome, including community-wide changes such as fecal microbiota transplants, prebiotics, probiotics, and antibiotics, and more targeted approaches such as phage therapy and CRISPR-Cas. We conclude that although much remains to be done in untangling the basic biology of microbiome-directed therapies in animals, the rapid progress currently being made in human medicine and the examples to date of application of probiotics and other microbiome-directed therapies in taxa ranging from horses to salamanders to bees suggest excellent prospects for these technologies as they are further developed and as data on both the…

  5. 5
    top 2.9%

    Cancer drug development: The missing links

    Ajaikumar Bahulayan Kunnumakkara, Devivasha Bordoloi, Bethsebie Lalduhsaki Sailo, Nand Kishor Roy, Krishan Kumar Thakur and 4 more

    112 citationsOpen accessdoi:10.1177/1535370219839163OpenAlex

    Show abstract

    Although better science and technology has been linked with better health care, however, reality is much different. Although America and most of Europe are equipped with most advanced science and technology, paradoxically cancer incidence is highest in the world. This indicates that science and technology alone is not sufficient in treating diseases like cancer. It is also now well recognized that more than 95% of the drugs/compounds that kill either cancer cells in culture or regress the tumors in animals, fail in phase I clinical trials in humans, indicating that most pre-clinical models of cancer are inadequate. In addition, most of the anticancer drugs that are approved by the regulatory agencies such as FDA either has no effect on the overall survival of the cancer patient or may provide an increase in few months in overall survival. This is despite the fact that most targeted therapies that are currently available are highly expensive; thus suggesting the lack of affordability. This review is meant to focus on some of these problems in detail and then provide potential…

  6. 6
    top 3.5%

    Microtubules: Evolving roles and critical cellular interactions

    Caitlin M. Logan, A. Sue Menko

    110 citationsOpen accessdoi:10.1177/1535370219867296OpenAlex

    Show abstract

    Microtubules are cytoskeletal elements known as drivers of directed cell migration, vesicle and organelle trafficking, and mitosis. In this review, we discuss new research in the lens that has shed light into further roles for stable microtubules in the process of development and morphogenesis. In the lens, as well as other systems, distinct roles for characteristically dynamic microtubules and stabilized populations are coming to light. Understanding the mechanisms of microtubule stabilization and the associated microtubule post-translational modifications is an evolving field of study. Appropriate cellular homeostasis relies on not only one cytoskeletal element, but also rather an interaction between cytoskeletal proteins as well as other cellular regulators. Microtubules are key integrators with actin and intermediate filaments, as well as cell–cell junctional proteins and other cellular regulators including myosin and RhoGTPases to maintain this balance. Impact statement The role of microtubules in cellular functioning is constantly expanding. In this review, we examine new and…

  7. 7
    top 4.1%

    Cardiac microtubules in health and heart disease

    Matthew A. Caporizzo, Christina Yingxian Chen, Benjamin L. Prosser

    109 citationsOpen accessdoi:10.1177/1535370219868960OpenAlex

    Show abstract

    Cardiomyocytes are large (∼40,000 µm 3 ), rod-shaped muscle cells that provide the working force behind each heartbeat. These highly structured cells are packed with dense cytoskeletal networks that can be divided into two groups—the contractile (i.e. sarcomeric) cytoskeleton that consists of filamentous actin-myosin arrays organized into myofibrils, and the non-sarcomeric cytoskeleton, which is composed of β- and γ-actin, microtubules, and intermediate filaments. Together, microtubules and intermediate filaments form a cross-linked scaffold, and these networks are responsible for the delivery of intracellular cargo, the transmission of mechanical signals, the shaping of membrane systems, and the organization of myofibrils and organelles. Microtubules are extensively altered as part of both adaptive and pathological cardiac remodeling, which has diverse ramifications for the structure and function of the cardiomyocyte. In heart failure, the proliferation and post-translational modification of the microtubule network is linked to a number of maladaptive processes, including the…

  8. 8
    top 4.7%

    IL-12 and IL-23/Th17 axis in systemic lupus erythematosus

    Maddalena Larosa, Margherita Zen, Mariele Gatto, Diogo Jesús, Elisabetta Zanatta and 3 more

    107 citationsOpen accessdoi:10.1177/1535370218824547OpenAlex

    Show abstract

    Systemic lupus erythematosus (SLE) is a very complex disease where multiple immunological pathways can concur in inducing tissue damage. Cytokines are key mediators in this process and among them the role of interleukin (IL)-12 and the IL-23/Th17 axis has recently emerged. IL-12 and IL-23 have a heterodimeric structure with a common subunit, named p40. Although they share a partially common structure, their functions appear slightly different. Indeed, IL-12 is a key cytokine in inducing an efficient T helper 1 (Th1) response and in Th differentiation, while IL-23 plays a crucial role in chronic inflammation and Th17 cell activation, which results in IL-17 secretion. The increasing knowledge on the interaction between IL-12 and IL-23/Th17 axis in the development of autoimmune diseases has led to the identification of new therapeutic strategies targeting these immunological pathways. IL-23/Th17 axis has recently been suggested to be essential in developing lupus nephritis, both in mice and in humans. In keeping with these observations, ustekinumab, a fully human IgG1κ monoclonal…

  9. 9
    top 5.3%

    Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment

    Elisabetta Zanatta, Pamela Polito, Giulia Famoso, Maddalena Larosa, Elena De Zorzi and 3 more

    86 citationsOpen accessdoi:10.1177/1535370218824101OpenAlex

    Show abstract

    Pulmonary arterial hypertension (PAH) is a serious complication of connective tissue disorders (CTDs), and CTD-PAH is the second cause of PAH after the idiopathic form. PAH is characterized by increased pulmonary arterial pressure and pulmonary vascular resistance, which can lead to right heart failure and death. About 90% of CTD-PAH cases are associated with systemic sclerosis (SSc, 74%), mixed connective tissue disease (MCTD, 8%) or systemic lupus erythematosus (SLE, 8%). CTD-PAH has also been reported, albeit rarely, in Sjögren syndrome, inflammatory idiopathic myopathies and rheumatoid arthritis. As for idiopathic PAH, the impaired production of vasoactive mediators such as nitric oxide and prostacyclin, and the increased production of vasoconstrictors and proliferative mediators such as endothelin-1, affect the vascular tone and promote vascular remodeling. Moreover, there is growing evidence suggesting that inflammation and autoimmunity may contribute to the genesis and progression of CTD-PAH, especially in SLE and MCTD patients who require an early administration of…

  10. 10
    top 5.8%

    LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis

    Qing Ge, Li Zhao, Xiao‐Min Ren, Peng Ye, Zuo‐Ying Hu

    81 citationsOpen accessdoi:10.1177/1535370219861283OpenAlex

    Show abstract

    Diabetic cardiomyopathy, which refers to the destruction of the structure and function of the heart, is the primary cause of heart failure due to diabetes. LCZ696 is the first angiotensin receptor-neprilysin inhibitor (ARNi) to be used clinically. Our study investigated the role played by LCZ696 during diabetic cardiomyopathy and explored the potential mechanisms underlying these effects. Diabetes was induced by injecting streptozotocin intraperitoneally into mice, and the mice were then divided randomly into two groups: one group was treated with LCZ696 (60 mg/kg/d) for 16 weeks, and the other received no treatment. The H9C2 cardiomyoblast cell line was treated with LCZ696 under high-glucose (HG) conditions. The levels of apoptotic (Bax, Bcl-2 and cleaved caspase-3) and pro-inflammatory factors [nuclear factor (NF)-κB, c-Jun N-terminal kinase (JNK) and p38 mitogen-activated kinase (MAPK)] were assessed in heart tissues from diabetic and normal mice and in H9C2 cells. The heart tissue structures and cardiac functions of diabetic mice were compared with those of normal mice, using…

How to read this list

The cohort is every article, review and book chapter OpenAlex attributes to Experimental Biology and Medicine with publication year 2019, excluding retracted works and paratext such as editorials and errata. The top 10 by citation count are listed; the percentile is the rank divided by the cohort size. 10 of the 10 entries have an abstract in OpenAlex. Counts were read on 29 October 2026 and will not be updated on this page, so a quoted rank stays verifiable. Full rules on the methodology page.

Other journals, same idea

Work with these 10 papers in Kahubi

  • The papers land in your library with their DOIs
  • Ask anything across all of them, with citations
  • Draft a literature review from the same sources

Free plan, no card. Your files stay private unless you share them.

Reading several of these?

Kahubi reads papers with you, keeps every citation traceable and drafts with sources you can check. Free plan, no card.